|
1
|
Stappert L, Roese-Koerner B and Brustle O:
The role of microRNAs in human neural stem cells, neuronal
differentiation and subtype specification. Cell Tissue Res.
359:47–64. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Villegas-Ruiz V, Juárez-Méndez S,
Pérez-González OA, Arreola H, Paniagua-García L, Parra-Melquiadez
M, Peralta-Rodríguez R, López-Romero R, Monroy-García A,
Mantilla-Morales A, et al: Heterogeneity of microRNAs expression in
cervical cancer cells: Over-expression of miR-196a. Int J Clin Exp
Pathol. 7:1389–1401. 2014.PubMed/NCBI
|
|
3
|
Ye JJ and Cao J: MicroRNAs in colorectal
cancer as markers and targets: Recent advances. World J
Gastroenterol. 20:4288–4299. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
He B, Yin B, Wang B, Xia Z, Chen C and
Tang J: MicroRNAs in esophageal cancer (review). Mol Med Rep.
6:459–465. 2012.PubMed/NCBI
|
|
5
|
Ahmad A, Ginnebaugh KR, Yin S,
Bollig-Fischer A, Reddy KB and Sarkar FH: Functional role of
miR-10b in tamoxifen resistance of ER-positive breast cancer cells
through down-regulation of HDAC4. BMC Cancer. 15:5402015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Knirsh R, Ben-Dror I, Modai S, Shomron N
and Vardimon L: MicroRNA 10b promotes abnormal expression of the
proto-oncogene c-Jun in metastatic breast cancer cells. Oncotarget.
7:59932–59944. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhen L, Li J, Zhang M and Yang K: MiR-10b
decreases sensitivity of glioblastoma cells to radiation by
targeting AKT. J Biol Res (Thessalon). 23:142016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ma L, Teruya-Feldstein J and Weinberg RA:
Tumour invasion and metastasis initiated by microRNA-10b in breast
cancer. Nature. 449:682–688. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Short MW, Burgers KG and Fry VT:
Esophageal cancer. Am Fam Physician. 95:22–28. 2017.PubMed/NCBI
|
|
10
|
Lin Y, Totsuka Y, Shan B, Wang C, Wei W,
Qiao Y, Kikuchi S, Inoue M, Tanaka H and He Y: Esophageal cancer in
high-risk areas of China: Research progress and challenges. Ann
Epidemiol. 27:215–221. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu H, Yao Y, Meng F, Qian X, Jiang X, Li
X, Gao Z and Gao L: Predictive value of serum miR-10b, miR-29c, and
miR-205 as promising biomarkers in esophageal squamous cell
carcinoma screening. Medicine (Baltimore). 94:e15582015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Massagué J: TGFbeta in cancer. Cell.
134:215–230. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mishra L, Derynck R and Mishra B:
Transforming growth factor-beta signaling in stem cells and cancer.
Science. 310:68–71. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Madhunapantula SV and Robertson GP: The
PTEN-AKT3 signaling cascade as a therapeutic target in melanoma.
Pigment Cell Melanoma Res. 22:400–419. 2010. View Article : Google Scholar
|
|
15
|
Georgescu MM: PTEN tumor suppressor
Network in PI3K-Akt pathway control. Genes Cancer. 1:1170–1177.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jamali L, Tofigh R, Tutunchi S, Panahi G,
Borhani F, Akhavan S, Nourmohammadi P, Ghaderian SMH, Rasouli M and
Mirzaei H: Circulating microRNAs as diagnostic and therapeutic
biomarkers in gastric and esophageal cancers. J Cell Physiol.
233:8538–8550. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods Dec. 25:402–408. 2001.
View Article : Google Scholar
|
|
18
|
Xu W, Yang Z, Zhou SF and Lu N:
Posttranslational regulation of phosphatase and tensin homolog
(PTEN) and its functional impact on cancer behaviors. Drug Des
Devel Ther. 8:1745–1751. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bahena-Ocampo I, Espinosa M,
Ceballos-Cancino G, Lizarraga F, Campos-Arroyo D, Schwarz A,
Garcia-Lopez P, Maldonado V and Melendez-Zajgla J: miR-10b
expression in breast cancer stem cells supports self-renewal
through negative PTEN regulation and sustained AKT activation. EMBO
Rep. 17:10812016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang W: Study of miR-10b regulatory
mechanism for epithelial-mesenchymal transition, invasion and
migration in nasopharyngeal carcinoma cells. Oncol Lett.
14:7207–7210. 2017.PubMed/NCBI
|
|
21
|
Zhang Y, Liao RB, Hu LL, Tong BX, Hao TF
and Wu HJ: The microRNA miR-10b as a potentially promising
biomarker to predict the prognosis of cancer patients: A
meta-analysis. Oncotarget. 8:104543–104551. 2017.PubMed/NCBI
|
|
22
|
Tian Y, Luo A, Cai Y, Su Q, Ding F, Chen H
and Liu Z: MicroRNA-10b promotes migration and invasion through
KLF4 in human esophageal cancer cell lines. J Biol Chem.
285:7986–7994. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Carlsson J, Christiansen J, Davidsson S,
Giunchi F, Fiorentino M and Sundqvist P: The potential role of
miR-126, miR-21 and miR-10b as prognostic biomarkers in renal cell
carcinoma. Oncol Lett. 17:4566–4574. 2019.PubMed/NCBI
|
|
24
|
Zhang J, Yang J, Zhang X, Xu J, Sun Y and
Zhang P: MicroRNA-10b expression in breast cancer and its clinical
association. PLoS One. 13:e01925092018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hujie G, Zhou SH, Zhang H, Qu J, Xiong XW,
Hujie O, Liao CG and Yang SE: MicroRNA-10b regulates
epithelial-mesenchymal transition by modulating KLF4/KLF11/Smads in
hepatocellular carcinoma. Cancer Cell Int. 18:102018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Moustakas A and Heldin CH: The regulation
of TGFbeta signal transduction. Development. 136:3699–3714. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pickup M, Novitskiy S and Moses HL: The
roles of TGF beta in the tumour microenvironment. Nat Rev Cancer.
13:788–799. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zheng T and Yang J: Mechanism of
transforming growth factor β in patients with hepatocellular
carcinoma. Chin J Hepatobiliary Surg. 6:425–428. 2016.
|
|
29
|
He Z, Dong W, Li Q, Qin C and Li Y:
Sauchinone prevents TGF-β-induced EMT and metastasis in gastric
cancer cells. Biomed Pharmacother. 101:355–361. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Katsuno Y, Lamouille S and Derynck R:
TGF-beta signaling and epithelial-mesenchymal transition in cancer
progression. Curr Opin Oncol. 25:76–84. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ma C, Wei F, Xia H, Liu H, Dong X, Zhang
Y, Luo Q, Liu Y and Li Y: MicroRNA-10b mediates TGF-β1-regulated
glioblastoma proliferation, migration and epithelial-mesenchymal
transition. Int J Oncol. 50:1739–1748. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ouyang H, Gore J, Deitz S and Korc M:
MicroRNA-10b enhances pancreatic cancer cell invasion by
suppressing TIP30 expression and promoting EGF and TGF-beta
actions. Oncogene. 36:49522017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhong H, Wang HR, Yang S, Zhong JH, Wang
T, Wang C and Chen FY: Targeting Smad4 links microRNA-146a to the
TGF-beta pathway during retinoid acid induction in acute
promyelocytic leukemia cell line. Int J Hematol. 92:129–135. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu MX, Liao J, Xie M, Gao ZK, Wang XH,
Zhang Y, Shang MH, Yin LH, Pu YP and Liu R: miR-93-5p transferred
by exosomes promotes the proliferation of esophageal cancer cells
via intercellular communication by targeting PTEN. Biomed Environ
Sci. 31:171–185. 2018.PubMed/NCBI
|
|
35
|
Liang HX, Sun LB and Liu NJ: Neferine
inhibits proliferation, migration and invasion of U251 glioma cells
by down-regulation of miR-10b. Biomed Pharmacother. 109:1032–1040.
2019. View Article : Google Scholar : PubMed/NCBI
|
